KINGDON CAPITAL MANAGEMENT, L.L.C. - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 63 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
KINGDON CAPITAL MANAGEMENT, L.L.C. ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$9,706,000
-63.8%
4,000,000
-77.8%
0.44%
-64.5%
Q4 2013$26,828,000
-15.9%
18,000,000
-30.8%
1.23%
-21.6%
Q3 2013$31,918,000
+2.8%
26,000,0000.0%1.57%
-14.6%
Q2 2013$31,060,00026,000,0001.84%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
GRACE BROTHERS MANAGEMENT LLC 2,800,000$5,117,0004.90%
SILVERBACK ASSET MANAGEMENT LLC 18,209,000$33,322,0004.30%
RAVEN ROCK CAPITAL MANAGEMENT, LLC 1,000,000$1,990,0002.80%
Verition Fund Management LLC 5,504,000$10,062,0002.26%
CAMDEN ASSET MANAGEMENT L P /CA 26,798,000$48,856,0001.81%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,600,000$15,679,0001.60%
TENOR CAPITAL MANAGEMENT Co., L.P. 3,000,000$5,490,0001.46%
BASSO CAPITAL MANAGEMENT, L.P. 4,825,000$8,782,0001.40%
Wellesley Asset Management 12,564$23,006,0001.35%
WOLVERINE ASSET MANAGEMENT LLC 31,156,000$56,979,0001.11%
View complete list of SALIX PHARMACEUTICALS INC shareholders